• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在I型多发性内分泌腺瘤病背景下对药物治疗难治的佐林格-埃利森综合征

Zollinger Ellison Syndrome Refractory to Medical Therapy in the Setting of Multiple Endocrine Neoplasia Type I.

作者信息

Martino Brendan R, Manibusan Pedro

机构信息

Internal Medicine, Tripler Army Medical Center, Honolulu, USA.

Gastroenterology, Tripler Army Medical Center, Honolulu, USA.

出版信息

Cureus. 2022 Jun 30;14(6):e26468. doi: 10.7759/cureus.26468. eCollection 2022 Jun.

DOI:10.7759/cureus.26468
PMID:35919366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9338823/
Abstract

Multiple Endocrine Neoplasia 1 (MEN1) syndrome is a genetic condition arising from a mutation of the MEN1 gene resulting in neuroendocrine tumor formation. Patients with MEN1 are at a higher risk of developing Zollinger-Ellison syndrome (ZES) due to the growth of neuroendocrine tumors called gastrinomas that release gastrin leading to hypersecretion of acid in the stomach resulting in severe ulcerative disease of the upper GI tract. Our case is a 42-year-old female with newly diagnosed MEN1 syndrome, presenting with acute abdominal pain and dyspepsia refractory to medical management including proton pump inhibitors (PPI) and H2 antagonists. ZES was biochemically confirmed with a secretin stimulation test and dotatate positron emission tomography/computed tomography (PET/CT) revealed multiple areas of hyper-metabolic activity within the gastrinoma triangle. However, no discrete masses could be appreciated on endoscopic ultrasound (EUS) or CT imaging that could provide a target for surgical intervention. This case elucidates not only the difficulty of gastrinoma localization in medically refractory ZES but also reinforces the need to screen patients with MEN1 presenting with acute abdominal pain and dyspepsia for ZES.

摘要

多发性内分泌腺瘤病1型(MEN1)综合征是一种由MEN1基因突变引起的遗传性疾病,可导致神经内分泌肿瘤形成。由于名为胃泌素瘤的神经内分泌肿瘤生长,释放胃泌素,导致胃酸分泌过多,从而引起上消化道严重溃疡性疾病,MEN1患者患卓艾综合征(ZES)的风险更高。我们的病例是一名42岁新诊断为MEN1综合征的女性,表现为急性腹痛和消化不良,对包括质子泵抑制剂(PPI)和H2拮抗剂在内的药物治疗无效。通过促胰液素刺激试验在生化上确诊为ZES,并且钇[68Ga] DOTATATE正电子发射断层扫描/计算机断层扫描(PET/CT)显示在胃泌素瘤三角区内有多个高代谢活性区域。然而,在内镜超声(EUS)或CT成像上未发现可作为手术干预靶点的离散肿块。该病例不仅阐明了在药物难治性ZES中胃泌素瘤定位的困难,也强化了对出现急性腹痛和消化不良的MEN1患者进行ZES筛查的必要性。

相似文献

1
Zollinger Ellison Syndrome Refractory to Medical Therapy in the Setting of Multiple Endocrine Neoplasia Type I.在I型多发性内分泌腺瘤病背景下对药物治疗难治的佐林格-埃利森综合征
Cureus. 2022 Jun 30;14(6):e26468. doi: 10.7759/cureus.26468. eCollection 2022 Jun.
2
All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.今日关于胃泌素瘤你需要了解的一切 | 胃泌素瘤与卓-艾综合征:全面更新
J Neuroendocrinol. 2023 Apr;35(4):e13267. doi: 10.1111/jne.13267. Epub 2023 Apr 11.
3
Gastric Neuroendocrine Tumors胃神经内分泌肿瘤
4
[Comparison of clinical characteristics between sporadic gastrinoma and multiple endocrine neoplasia type 1-related gastrinoma].散发性胃泌素瘤与1型多发性内分泌肿瘤相关胃泌素瘤临床特征的比较
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Oct 25;24(10):875-882. doi: 10.3760/cma.j.cn.441530-20210719-00291.
5
Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.胃泌素瘤和卓-艾综合征:新旧疗法管理之间的路线图。
World J Gastroenterol. 2021 Sep 21;27(35):5890-5907. doi: 10.3748/wjg.v27.i35.5890.
6
Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature.1型多发性内分泌腺瘤病与佐林格-埃利森综合征:107例前瞻性研究并与文献报道的1009例进行比较
Medicine (Baltimore). 2004 Jan;83(1):43-83. doi: 10.1097/01.md.0000112297.72510.32.
7
Patients with multiple endocrine neoplasia type 1 with gastrinomas have an increased risk of severe esophageal disease including stricture and the premalignant condition, Barrett's esophagus.患有1型多发性内分泌腺瘤病且伴有胃泌素瘤的患者,发生包括狭窄以及癌前病变巴雷特食管在内的严重食管疾病的风险增加。
J Clin Endocrinol Metab. 2006 Jan;91(1):204-12. doi: 10.1210/jc.2005-1349. Epub 2005 Oct 25.
8
Secretin Stimulation Test and Early Diagnosis of Gastrinoma in MEN1 Syndrome: Survey on the MEN1 Florentine Database.促胰液素刺激试验与MEN1综合征中胃泌素瘤的早期诊断:基于MEN1佛罗伦萨数据库的调查
J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2110-e2123. doi: 10.1210/clinem/dgab903.
9
A case of type 1 multiple endocrine neoplasia with esophageal stricture successfully treated with endoscopic balloon dilation and local steroid injection combined with surgical resection of gastrinomas.1例1型多发性内分泌肿瘤伴食管狭窄经内镜球囊扩张、局部类固醇注射联合胃泌素瘤手术切除成功治疗。
BMC Gastroenterol. 2017 Mar 7;17(1):37. doi: 10.1186/s12876-017-0597-6.
10
Management of patients with Zollinger-Ellison syndrome.卓-艾综合征患者的管理
Annu Rev Med. 1995;46:395-411. doi: 10.1146/annurev.med.46.1.395.

引用本文的文献

1
Successful Lifetime/Long-Term Medical Treatment of Acid Hypersecretion in Zollinger-Ellison Syndrome (ZES): Myth or Fact? Insights from an Analysis of Results of NIH Long-Term Prospective Studies of ZES.卓-艾综合征(ZES)胃酸分泌过多的终身/长期成功医学治疗:神话还是现实?来自美国国立卫生研究院ZES长期前瞻性研究结果分析的见解
Cancers (Basel). 2023 Feb 21;15(5):1377. doi: 10.3390/cancers15051377.

本文引用的文献

1
Validity of Secretin Stimulation Testing on Proton Pump Inhibitor Therapy for Diagnosis of Zollinger-Ellison Syndrome.质子泵抑制剂治疗下促胰液素刺激试验对 Zollinger-Ellison 综合征诊断的有效性。
Am J Gastroenterol. 2021 Nov 1;116(11):2216-2221. doi: 10.14309/ajg.0000000000001487.
2
Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing.在质子泵抑制剂时代、胃泌素检测存在缺陷、影像检查敏感且胃酸分泌检测受限的情况下对卓-艾综合征的诊断
Int J Endocr Oncol. 2017;4(4):167-185. doi: 10.2217/ije-2017-0018. Epub 2017 Oct 11.
3
The Zollinger-Ellison syndrome: is there a role for somatostatin analogues in the treatment of the gastrinoma?
佐林格-埃利森综合征:生长抑素类似物在治疗胃泌素瘤中有作用吗?
Endocrine. 2018 Apr;60(1):15-27. doi: 10.1007/s12020-017-1420-4. Epub 2017 Oct 10.
4
Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study.舒尼替尼治疗胰腺神经内分泌肿瘤:III 期随机研究的更新无进展生存期和最终总生存期数据。
Ann Oncol. 2017 Feb 1;28(2):339-343. doi: 10.1093/annonc/mdw561.
5
Zollinger-Ellison syndrome: Revelation of the gastrinoma triangle.佐林格-埃利森综合征:胃泌素瘤三角的揭示。
Radiol Case Rep. 2015 Dec 3;10(1):827. doi: 10.2484/rcr.v10i1.827. eCollection 2015.
6
Zollinger-Ellison syndrome: classical considerations and current controversies.佐林格-埃利森综合征:经典观点与当前争议。
Oncologist. 2014 Jan;19(1):44-50. doi: 10.1634/theoncologist.2013-0369. Epub 2013 Dec 6.
7
Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1).《多发性内分泌肿瘤 1 型(MEN1)临床实践指南》。
J Clin Endocrinol Metab. 2012 Sep;97(9):2990-3011. doi: 10.1210/jc.2012-1230. Epub 2012 Jun 20.
8
Everolimus for advanced pancreatic neuroendocrine tumors.依维莫司治疗晚期胰腺神经内分泌肿瘤。
N Engl J Med. 2011 Feb 10;364(6):514-23. doi: 10.1056/NEJMoa1009290.
9
EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors.EUS 对于胰腺神经内分泌肿瘤的检测仍然优于多排计算机断层扫描。
Gastrointest Endosc. 2011 Apr;73(4):691-6. doi: 10.1016/j.gie.2010.08.030. Epub 2010 Nov 10.
10
Radiotherapy for pancreatic neuroendocrine tumors.胰腺神经内分泌肿瘤的放射治疗
Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1196-200. doi: 10.1016/j.ijrobp.2008.12.044. Epub 2009 Mar 26.